Trials / Completed
CompletedNCT00642876
PRESTIGE® Cervical Disc Study
Investigation of the PRESTIGE® Cervical Disc Device at a Single Level for Symptomatic Cervical Disc Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 541 (actual)
- Sponsor
- Medtronic Spinal and Biologics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical investigation is to evaluate the safety and effectiveness of the ACD in the single level surgical treatment of patients with symptomatic cervical degenerative disc disease. The primary follow-up information obtained from this clinical investigation are used to support a PMA application for the ACD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Allograft Fusion and ATLANTIS™ Cervical Plate System | The patients that received the control treatment underwent a single level anterior cervical fusion procedure involving allograft bone and the ATLANTIS™ Cervical Plate System. |
| DEVICE | PRESTIGE® Cervical Disc | The PRESTIGE® Cervical Disc is a stainless steel device that was inserted into the intervertebral disc space. The device is composed of two metal plates that interface via a ball and socket mechanism permitting segmental spinal motion. |
Timeline
- Start date
- 2002-10-01
- Primary completion
- 2006-07-01
- Completion
- 2013-05-01
- First posted
- 2008-03-25
- Last updated
- 2023-05-10
Locations
31 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00642876. Inclusion in this directory is not an endorsement.